Tetra Discovery Partners Secures $4.28 Million in VC Funding for New Drug

In raising an additional $4.28 million in venture capital funding, Tetra Discovery Partners LLC plans to support the ongoing clinical trials for a new drug to treat Alzheimer’s disease.

The Grand Rapids- and Kalamazoo-based Tetra Discovery Partners netted the funding as part of a $7.27 million Series A venture round that CEO Mark Gurney expects will successfully conclude within the next three months.

Read the rest of the article.


Leave a Reply

Your email address will not be published. Required fields are marked *